DR.REDDY'S LABORATORIES LTD. - Completion of Audit of plant by US FDA

Dr Reddys Laboratories Ltd has informed BSE that the audit of the Companys API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017. The Company have been issued a Form 483 with three observations, which the Company is addressing.